ArticleActa medica Philippina2024
An Evaluation of the Technical Review Process of the UP PGH Department of Medicine.
Article in Acta medica Philippina, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: The technical review process involves an evaluation of the scientific merits of the research proposal and is a necessary part of the ethics review but can be done separately and ahead of the formal ethics evaluation. The aim of this paper is to determine the efficiency and quality of the technical review process of the Philippine General Hospital (PGH) Department of Medicine Research Office. Methods: This is a cross-sectional study which involved retrieval of the technical review forms of protocols evaluated in the PGH Department of Medicine from the years 2018-2019, and then an evaluation of these metrics: timelines of the review process indicating efficiency, including time from (1) receipt of submission to receipt of reviewer (secretariat efficiency); (2) receipt of reviewer to first decision (reviewer metric); (3) initial receipt to final decision (total review time); and (4) number of re-submissions. To evaluate the quality of the reviews, the specific review findings in each part or section of the protocol were also extracted. Results: In the years 2018-2019, a total of 199 protocols underwent technical review, with one protocol having no further data after the submission so only 198 proposals were analyzed. Majority of the protocols or 139/198 (70.2%) were submitted only once and were approved without comments, while the remaining 59/198 (29.8%) were submitted twice for technical review (mode of 1, mean of 1.32). The protocols were sent to the reviewers within the same day of receipt 100% of the time. The time from receipt of submission to receipt of reviewer was within the same day and the time from receipt of reviewer to first decision (mean, standard deviation working days) was 10.52, 8.54 days, range 0-51 days. Around one-fourth (21.51%) of the protocols were returned to the secretariat beyond the 14-working day deadline. The time from second review of technical reviewer to return to secretariat was a mean, SD of 6.72, 6.45 days, with a range of 1 day to 36 days, and time from initial receipt to final decision was a mean of 16.16 days, SD 18.3 days, range 0-111 days. The most common reason for the delay was the failure of the author to resubmit the paper for the second review in 17/23 (74%), while the other reason was the long duration of the initial review by the reviewer in 6/23 (26%). Half of the protocols (49.5%) were returned without comments. Majority of the comments were on the methodology. Conclusions: The technical review process is generally efficient with each step within the acceptable timelines. However, for 12% of the protocols, the over-all review process was still prolonged (>28 working days) because of the failure of the author to submit the paper for the second review in 74% of cases, and the long duration of the initial review in 26% of papers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.